Effect of Intra-Dialytic Muscle Energy Technique on Restless Leg Syndrome in Hemodialysis Patients
Completed · Not applicable
Conditions studied: Restless Legs Syndrome (RLS), End-Stage Renal Disease
In brief
The goal of this clinical trial is to learn if intra-dialytic Muscle Energy Technique (MET) can reduce symptoms of restless legs syndrome (RLS) in people with end-stage renal disease (ESRD) receiving maintenance hemodialysis. The study also aims to learn if this treatment can improve sleep quality, muscle strength, blood pressure, and oxygen saturation. The main questions it aims to answer are: * Does intra-dialytic Muscle Energy Technique reduce the severity of restless legs syndrome? * Does intra-dialytic Muscle Energy Technique improve sleep quality, muscle strength, blood pressure, and oxygen saturation? Researchers compared people who received intra-dialytic Muscle Energy Technique together with routine medical treatment and hemodialysis with people who received routine medical treatment and hemodialysis alone to find out whether adding Muscle Energy Technique provides greater benefits. Participants: * Were randomly placed into one of two groups. * Received routine medical treatment and hemodialysis. * Received intra-dialytic Muscle Energy Technique during the second hour of hemodialysis if they were in the intervention group. * Had three treatment sessions each week for eight weeks. * Had assessments before and after the eight-week treatment.
Key facts
- Study ID
- NCT07748065
- Run by
- Cairo University
- People needed
- 60
- Starts
- 2025-08-01
- Expected to finish
- 2026-04-30
- Last updated by the study team
- 2026-08-05
Who can join
Age: 55 and older, up to 65. Sex: any. Healthy volunteers: accepted.
You may qualify if…
- Age 55 to 65 years.
- Diagnosed with end-stage renal disease (ESRD).
- Receiving maintenance hemodialysis three times per week for at least one year, with each session lasting approximately 4 hours.
- Diagnosed with restless legs syndrome using the International Restless Legs Syndrome Study Group (IRLSSG) Rating Scale.
- Under regular medical care.
- Body mass index (BMI) between 25.8 and 28.8 kg/m².
- Men and women were eligible.
You may not qualify if…
- Resting systolic blood pressure >200 mmHg and/or diastolic blood pressure >120 mmHg.
- Neurological disorders (e.g., stroke or head injury) associated with chronic pain.
- Uncontrolled pulmonary disease.
- Cognitive impairment or mental disorders that prevented participation in the intervention.
- Missed more than two weeks of the intervention program or withdrew from the study.
- Severe obesity.
- Malignant disease.
- Unstable angina, uncontrolled cardiac arrhythmia, decompensated heart failure, acute pericarditis, or myocarditis.
- Hearing impairment.
- Receiving muscle relaxant medications.
Where it is running
- Tala Central Hospital — Tala, Menoufia Governorate, Egypt
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.